Low penetrance susceptibility to glioma is caused by the TP53 variant rs78378222
Victor Enciso-Mora, Richard S. Houlston(Institute of Cancer Research), Minouk J. Schoemaker(Institute of Cancer Research), Khê Hoang‐Xuan(Sorbonne Université), Melissa L. Bondy(The University of Texas MD Anderson Cancer Center), Marianne Labussière(Centre National de la Recherche Scientifique), Matthias Simon(University of Bonn), Konstantinos Gousias(European University Cyprus), Anthony J. Swerdlow(Institute of Cancer Research), Konstantin Strauch(Zimmer Biomet (Netherlands)), Andreas G. Franke(University of Applied Labour Studies of the Federal Employment Agency), Fay J. Hosking(Institute of Cancer Research), Martina Müller‐Nurasyid(Helmholtz Zentrum München), J. Schramm(University Hospital Bonn), Agustí Alentorn(Allen Institute for Brain Science), Yanhong Liu(Wuhan University), Peter Broderick(Institute of Cancer Research), Marc Sanson(Centre National de la Recherche Scientifique), Pietro Ciccarino(Sorbonne Université), Ching C. Lau(University of Hong Kong), Diana Zélénika(Centre National de Recherche en Génomique Humaine), Susanne Moebus(University of Bonn), Anna Luisa Di Stefano(Hôpital Foch), Georgina Armstrong(Baylor College of Medicine), Ahmed Idbaïh(Centre National de la Recherche Scientifique), Mark Lathrop(Commissariat à l'Énergie Atomique et aux Énergies Alternatives), S. Schreiber(Erasmus MC), Sarah Hepworth(University of Leeds), J-Y Delattre(Sorbonne Université), Marta Rossetto(Sorbonne Université), Lewin Eisele(Christian-Albrechts-Universität zu Kiel), Y. Marie, Sanjay Shete(The University of Texas MD Anderson Cancer Center)
Cited by 59
Related Papers
Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease
|Nature Genetics|2013|4.7k
Genome-wide association defines more than 30 distinct susceptibility loci for Crohn's disease
|Nature Genetics|2008|2.6k
Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study
|The Lancet|2020|1.8k